Vol.

No.

May 14, 2021May 14, 2021

DOWNLOAD THE PDF

St. Jude’s $11.5B, six-year plan aims to improve global outcomes for children with cancer and catastrophic diseases

Cover Story

Conversation with The Cancer Letter

St. Jude’s $11.5B, six-year plan aims to improve global outcomes for children with cancer and catastrophic diseases

By Matthew Bin Han Ong

Small dreams have no power to move hearts, and in a new six-year strategic plan, St. Jude Children’s Research Hospital is thinking very big. What would it take to drastically increase cure rates for childhood cancer worldwide?

Real-world Evidence

Cancer trials are getting harder to complete, suggesting a role for more powerful RWE, AI solutions

By Matthew Bin Han Ong

Conversation with The Cancer Letter Film & TV

“1001cuts”—A GYN oncologist examines the toll of sexism in the OR

By Alexandria Carolan

Cancer History Project Free Guest Editorial

Paul Calabresi: A founder and giant in the field of medical oncology

By Fred Schiffman

Free In the Archives

Breaking barriers: women in oncology, learning from survivors, and keen-eyed pioneers

Clinical Trials & Tribulations

It’s time to rethink clinical trials in a post-pandemic world

By Dana Dornsife

In Brief

Dana-Farber receives $50M gift from the Hale family for pancreatic cancer research

Christopher Lathan named chief clinical access and equity officer at Dana-Farber

MD Anderson, Broad Institute establish translational research platform focused on rare cancers

Jordan Anaokar named site director for radiology at Fox Chase

Pawel Kalinski named endowed chair at Roswell Park

Jeffrey Miller receives $9M NCI grant to develop off-the-shelf NK cells

Leukemia & Lymphoma Society establishes IMPACT research grants to help underserved patients access clinical trials

Funding Opportunities

Melanoma Research Foundation RFPs for 2021 Career Development Awards

Clinical Roundup

Phase III KEYNOTE-522 trial meets dual primary endpoint of event-free survival in high-risk early-stage TNBC

In phase III trial, Libtayo demonstrates improved OS in advanced cervical cancer

People at high genetic risk for colorectal cancer benefit more from lifestyle changes than those at low risk

Single-cell map of early stage lung cancer and normal lung sheds light on tumor development, new therapeutic targets

Winship study shows increased disease-free survival in prostate cancer in men whose post-surgery treatment was informed by fluciclovine PET imaging

Prototype shows promise as approach to countering pancreatic cancer

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues